Swiss Life Forecast, price target & analysts
Swiss Life Target price 2025 - Analyst rating & recommendation
Swiss Life Classifications & Recommendation:
Swiss Life Price Target
| Target Price | CHF805.80 |
| Price | CHF802.80 |
| Potential | 0.37% |
| Number of Estimates | 14 |
| 14 Analysts have issued a price target Swiss Life 2026 . The average Swiss Life target price is CHF805.80. This is 0.37% higher than the current stock price. The highest price target is CHF945.00 17.71% , the lowest is CHF681.75 15.08% . | |
| A rating was issued by 18 analysts: 10 Analysts recommend Swiss Life to buy, 6 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Swiss Life stock has an average upside potential 2026 of 0.37% . Most analysts recommend the Swiss Life stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 10.92 | 15.01 |
| 16.63% | 37.49% | |
| Net Margin | 11.12% | 8.36% |
| 34.46% | 24.84% |
7 Analysts have issued a sales forecast Swiss Life 2025 . The average Swiss Life sales estimate is CHF15.0b . This is 37.49% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.9b 100.39% , the lowest is CHF3.4b 68.87% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | CHF10.9b | 16.63% |
|---|---|---|
| 2025 | CHF15.0b | 37.49% |
| 2026 | CHF21.1b | 40.39% |
| 2027 | CHF20.1b | 4.81% |
| 2028 | CHF9.4b | 52.91% |
| 2029 | CHF9.5b | 1.00% |
| 2030 | CHF8.7b | 9.24% |
| 2031 | CHF8.7b | 0.99% |
| 2032 | CHF8.8b | 1.01% |
14 Swiss Life Analysts have issued a net profit forecast 2025. The average Swiss Life net profit estimate is CHF1.3b . This is 3.33% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.4b 16.22% , the lowest is CHF679m 44.10% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | CHF1.2b | 12.10% |
|---|---|---|
| 2025 | CHF1.3b | 3.33% |
| 2026 | CHF1.3b | 7.53% |
| 2027 | CHF1.4b | 4.42% |
| 2028 | CHF1.3b | 4.81% |
| 2029 | CHF1.5b | 9.78% |
| 2030 | CHF1.6b | 11.10% |
| 2031 | CHF1.6b | 1.52% |
| 2032 | CHF1.8b | 13.94% |
Net Margin
| 2024 | 11.12% | 34.46% |
|---|---|---|
| 2025 | 8.36% | 24.84% |
| 2026 | 6.40% | 23.44% |
| 2027 | 7.02% | 9.69% |
| 2028 | 14.20% | 102.28% |
| 2029 | 15.43% | 8.66% |
| 2030 | 18.89% | 22.42% |
| 2031 | 18.42% | 2.49% |
| 2032 | 20.77% | 12.76% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 42.29 | 43.97 |
| 14.27% | 3.97% | |
| P/E | 18.26 | |
| EV/Sales | 2.15 |
14 Analysts have issued a Swiss Life forecast for earnings per share. The average Swiss Life EPS is CHF43.97 . This is 5.24% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF49.46 18.38% , the lowest is CHF23.78 43.08% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | CHF42.29 | 14.27% |
|---|---|---|
| 2025 | CHF43.97 | 3.97% |
| 2026 | CHF47.28 | 7.53% |
| 2027 | CHF49.36 | 4.40% |
| 2028 | CHF46.99 | 4.80% |
| 2029 | CHF51.59 | 9.79% |
| 2030 | CHF57.31 | 11.09% |
| 2031 | CHF56.44 | 1.52% |
| 2032 | CHF64.30 | 13.93% |
P/E ratio
| Current | 19.21 | 10.21% |
|---|---|---|
| 2025 | 18.26 | 4.97% |
| 2026 | 16.98 | 7.01% |
| 2027 | 16.26 | 4.24% |
| 2028 | 17.08 | 5.04% |
| 2029 | 15.56 | 8.90% |
| 2030 | 14.01 | 9.96% |
| 2031 | 14.22 | 1.50% |
| 2032 | 12.48 | 12.24% |
Based on analysts' sales estimates for 2025, the Swiss Life stock is valued at an EV/Sales of 2.15 and an P/S ratio of 1.52 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.95 | 62.98% |
|---|---|---|
| 2025 | 2.15 | 27.15% |
| 2026 | 1.53 | 28.77% |
| 2027 | 1.61 | 5.05% |
| 2028 | 3.41 | 112.36% |
| 2029 | 3.38 | 0.99% |
| 2030 | 3.73 | 10.18% |
| 2031 | 3.69 | 0.98% |
| 2032 | 3.65 | 1.00% |
P/S ratio
| Current | 2.09 | 41.97% |
|---|---|---|
| 2025 | 1.52 | 27.27% |
| 2026 | 1.08 | 28.76% |
| 2027 | 1.14 | 5.05% |
| 2028 | 2.42 | 112.36% |
| 2029 | 2.39 | 0.99% |
| 2030 | 2.64 | 10.18% |
| 2031 | 2.61 | 0.98% |
| 2032 | 2.59 | 1.00% |
Current Swiss Life Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
| DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Feb 05 2025 |
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Dec 12 2024 |
| BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2024 |
| HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Feb 05 2025 |
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Dec 12 2024 |
|
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Dec 08 2024 |
|
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
